KCT0006914招募中未知
Comparison of clinical outcomes between non-polymer drug-coated stent versus ultrathin strut biodegradable polymer drug-eluting stent in patients undergoing percutaneous coronary intervention: SMART-CHOICE 4 randomized trial
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 3,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 19(Year) 至 74(Year)（—）
- 性别
- All
入选标准
- •1)Subject must be at least 19 years of age
- •2)Subject who is able to understand risks, benefits and treatment alternatives and sign informed consent voluntarily.
- •3)Patients with at least one lesion with equal or greater than 50% diameter stenosis requiring treatment with drug-eluting stents (DES) in native coronary artery or graft
排除标准
- •1)Patients unable to provide consent
- •2)Patients with known intolerance major components of drug-eluting stents
- •3)Patients who have non-cardiac co-morbid conditions with life expectancy <1 year or that may result in protocol non-compliance (per site investigator’s medical judgment)
- •4)Pregnant or lactating women
- •5) patient with hemodynamic instability or psychogenic shock
研究者
相似试验
尚未招募
2 期
Comparison of clinical outcomes between polyvalent and monovalent antivenoms: a pilot studySnakebite patients requiring antivenomsSnakebiteAntivenomPolyvalentMonovalentThe Thai Red Cross SocietyTCTR20210826004King Chulalongkorn Memorial Hospital20
尚未招募
Unknown
Clinical outcomes of Monolithic CAD-CAM Graphene and Zirconia single crowns in the posterior region.CTRI/2024/06/068366MGM Dental College and Hospital
已完成
Unknown
Removing an abnormal maxillary labial frenum (a small band of tissue that connects the upper lip to the gums) using a scalpel and laserFrenectomy in patients with abnormal labial frenumOral HealthISRCTN10827581Damascus University40
已完成
不适用
To find out effect and safety of polyethylene glycol and sodium hyaluronate in patient with dry eye diseaseCTRI/2023/02/049510Pt BD Sharma PGIMS Rohtak50
招募中
4 期
Treatment of gum loss in gum disease individuals using animal derived membrane along with patients blood derived substancesCTRI/2024/05/067734kiran choudhary